scholarly article | Q13442814 |
P2093 | author name string | Pei-Ming Chu | |
Yi-Wen Liao | |||
Pei-Ling Hsieh | |||
Cheng-Chia Yu | |||
Fang-Wei Hu | |||
Ming-Yi Lu | |||
P2860 | cites work | Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression | Q28271211 |
Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway | Q28385231 | ||
Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis | Q28387038 | ||
Cancer drug resistance: an evolving paradigm | Q29616694 | ||
Tumour stem cells and drug resistance | Q29617742 | ||
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma | Q29620604 | ||
ABCG2 is required to control the sonic hedgehog pathway in side population cells with stem-like properties. | Q33966214 | ||
Nonadhesive Culture System as a Model of Rapid Sphere Formation with Cancer Stem Cell Properties | Q34168436 | ||
Bmi-1 Regulates Snail Expression and Promotes Metastasis Ability in Head and Neck Squamous Cancer-Derived ALDH1 Positive Cells | Q34170082 | ||
Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis | Q34218232 | ||
Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling | Q34331960 | ||
Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer | Q34349485 | ||
The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. | Q34702354 | ||
Isoliquiritigenin induces apoptosis and inhibits xenograft tumor growth of human lung cancer cells by targeting both wild type and L858R/T790M mutant EGFR. | Q34774462 | ||
Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway | Q46358702 | ||
Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling | Q46475690 | ||
Isoliquiritigenin, a flavonoid from licorice, relaxes guinea-pig tracheal smooth muscle in vitro and in vivo: role of cGMP/PKG pathway | Q46480563 | ||
Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. | Q46742618 | ||
Cyclooxygenase-2 plays a suppressive role for induction of apoptosis in isoliquiritigenin-treated mouse colon cancer cells | Q46884208 | ||
Isoliquiritigenin as a cause of DNA damage and inhibitor of ataxia-telangiectasia mutated expression leading to G2/M phase arrest and apoptosis in oral squamous cell carcinoma | Q52976397 | ||
Isoliquiritigenin, one of the antispasmodic principles of Glycyrrhiza ularensis roots, acts in the lower part of intestine | Q79486481 | ||
Analgesic and Uterine Relaxant Effects of Isoliquiritigenin, a Flavone from Glycyrrhiza glabra | Q83569425 | ||
Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells | Q86419308 | ||
Cancer stem cells: The challenges ahead | Q86523719 | ||
Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta | Q34793336 | ||
A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis | Q34803685 | ||
Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. | Q34981591 | ||
Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylation | Q35833171 | ||
Cancer stem cells: impact, heterogeneity, and uncertainty | Q35857599 | ||
The evolving concept of cancer and metastasis stem cells | Q36145729 | ||
Reassessment of the role of induction chemotherapy for head and neck cancer | Q36524702 | ||
GRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS axis in hepatocellular carcinoma | Q36545246 | ||
Mechanisms of chemoresistance in cancer stem cells | Q36591484 | ||
GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosis | Q36926745 | ||
Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium | Q37039595 | ||
Global epidemiology of oral and oropharyngeal cancer | Q37274268 | ||
Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways | Q37359214 | ||
Upregulation of Glucose-Regulated Protein 78 in Metastatic Cancer Cells Is Necessary for Lung Metastasis Progression | Q37391501 | ||
ABCG2: the key to chemoresistance in cancer stem cells? | Q37587219 | ||
Synthetic Isoliquiritigenin Inhibits Human Tongue Squamous Carcinoma Cells through Its Antioxidant Mechanism. | Q37624825 | ||
Isoliquiritigenin induces apoptosis and autophagy and inhibits endometrial cancer growth in mice | Q37687402 | ||
Cancer stem cells and self-renewal. | Q37763416 | ||
Targeting cancer stem cells to suppress acquired chemotherapy resistance | Q38149736 | ||
Chemical approaches to targeting drug resistance in cancer stem cells. | Q38211209 | ||
Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells | Q38302628 | ||
Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4. | Q38437805 | ||
Cell surface GRP78 facilitates hepatoma cells proliferation and migration by activating IGF-IR. | Q38847254 | ||
Photodynamic therapy with 5-aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells | Q39029356 | ||
Andrographolide impedes cancer stemness and enhances radio-sensitivity in oral carcinomas via miR-218 activation | Q39123992 | ||
Prognosis of oral squamous cell carcinoma patients with level IV/V metastasis: An observational study | Q39138334 | ||
Cancer stem cells: The root of tumor recurrence and metastases. | Q39160322 | ||
The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers | Q39618327 | ||
Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis | Q39942224 | ||
Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages | Q40009722 | ||
N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes | Q40091613 | ||
Activation and cross-talk between Akt, NF-kappaB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78. | Q40303607 | ||
Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin-dependent kinase-independent mechanism | Q40977936 | ||
A lymphocyte cell surface heat shock protein homologous to the endoplasmic reticulum chaperone, immunoglobulin heavy chain binding protein BIP. | Q41105188 | ||
Impairment of tumor‐initiating stem‐like property and reversal of epithelial–mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment | Q42717496 | ||
Concurrent expression of Oct4 and Nanog maintains mesenchymal stem-like property of human dental pulp cells | Q42997318 | ||
Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth. | Q44205082 | ||
Isoliquiritigenin, a flavonoid from licorice, plays a dual role in regulating gastrointestinal motility in vitro and in vivo | Q46207931 | ||
P433 | issue | 55 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lip and oral cavity carcinoma | Q55790434 |
P304 | page(s) | 93912-93923 | |
P577 | publication date | 2017-09-28 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Targeting oral cancer stemness and chemoresistance by isoliquiritigenin-mediated GRP78 regulation | |
P478 | volume | 8 |
Q98721099 | GRP78 targeting: Hitting two birds with a stone |
Q101136375 | HPV+ve/-ve oral-tongue cancer stem cells: A potential target for relapse-free therapy |
Q92259555 | Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy |
Q91981304 | Simultaneous Determination and Pharmacokinetic Characterization of Glycyrrhizin, Isoliquiritigenin, Liquiritigenin, and Liquiritin in Rat Plasma Following Oral Administration of Glycyrrhizae Radix Extract |
Search more.